Early Detection of Five Common Cancers Using the ctDNA Analysing Test

NCT05227261 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 9057

Last updated 2025-02-18

No results posted yet for this study

Summary

This is a multi-centre, prospective cohort study, aiming to evaluate a blood test in early detection of the four common cancers, based on the investigation of the circulating tumour DNA (ctDNA).

Primary objective: To evaluate the performance characteristics of the blood ctDNA test in early detecting cancers.

Secondary objectives:

* To evaluate the performance characteristics of the test in determining the origin of tumour, as compared to the findings of the imaging diagnostic tests.
* To determine the risk of cancers development in the high-risk population, as compared to that in the moderate-risk group.

Conditions

  • Cancer, Lung
  • Cancer, Breast
  • Cancer Liver
  • Cancer, Colorectal
  • Liquid Biopsy
  • Circulating Tumour DNA
  • Cancer, Gastric

Sponsors & Collaborators

  • Medical University of Ho Chi Minh City

    collaborator UNKNOWN
  • Hanoi Medical University

    collaborator OTHER
  • Hanoi Oncology Hospital

    collaborator UNKNOWN
  • Hue Central Hospital

    collaborator OTHER
  • Da Nang Oncology Hospital

    collaborator UNKNOWN
  • Thong Nhat Dong Nai General Hospital

    collaborator UNKNOWN
  • Dong Nai General Hospital

    collaborator UNKNOWN
  • Van Hanh General Hospital

    collaborator OTHER
  • Can Tho Oncology Hospital

    collaborator UNKNOWN
  • Medic Medical Center

    collaborator UNKNOWN
  • Le Van Thinh Hospital

    collaborator UNKNOWN
  • People's Hospital 115

    collaborator UNKNOWN
  • Xuyen A Hospital

    collaborator UNKNOWN
  • Medical Genetics Institute

    collaborator UNKNOWN
  • Gene Solutions

    lead INDUSTRY

Eligibility

Min Age
40 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-04-10
Primary Completion
2023-04-10
Completion
2024-04-10

Countries

  • Vietnam

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05227261 on ClinicalTrials.gov